The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy-Reference-Cited by-同舟云学术

The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy

Published:2015-11 Issue:11 Volume:33 Page:495.e9-495.e14
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Hsieh Meng-Che,Chiang Po-Hui,Rau Kun-Ming,Chen Yen-Yang,Su Yu-Li,Huang Cheng-Hua

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference29 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. European guidelines on upper tract urothelial carcinomas: 2013 update;Roupret;Eur Urol,2013

3. Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

4. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000

5. Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium;Sternberg;J Urol,1985

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Split-Dose Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Systematic Literature Review and Network Meta-Analysis;Clinical Genitourinary Cancer;2024-12

2. Epidemiology, treatments, and related biomarkers of locally advanced or metastatic urothelial carcinoma in Chinese population: A scoping review;Cancer Medicine;2023-06-30

3. A SEER-Medicare Based Quality Score for Patients With Metastatic Upper Tract Urothelial Carcinoma;Clinical Genitourinary Cancer;2023-06

4. Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real‐world study;Cancer Medicine;2023-03-23

5. First-line Chemotherapy Response Is Associated With Clinical Outcome During Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real World Retrospective Study;Anticancer Research;2023-02-28